MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • MassDevice Today
    • Cardiovascular
    • Clinical Trials
    • Legal News
    • Orthopedics
    • Regulatory/Compliance
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • More MedTech
    • Cosmetic/Aesthetic
    • Diabetes
    • Dialysis
    • Distribution
    • Imaging
    • Otolaryngology Ear, Nose & Throat
    • Pharma
    • Respiratory
    • Wound Care
  • Blog
  • DeviceTalks Podcasts
  • Resources
    • About MassDevice
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • White Papers
  • DeviceTalks
Home » NIH inks $5m partnership with PathMaker Neurosystems for MyoRegulator spasticity device

NIH inks $5m partnership with PathMaker Neurosystems for MyoRegulator spasticity device

February 7, 2018 By Fink Densford Leave a Comment

Share

Pathmaker Neurosystems

PathMaker Neurosystems said today it signed a $5 million cooperative partnership deal with the National Institutes of Health to support continued development of its MyoRegulator neurostimulation system designed to treat spasticity secondary to stroke.

The MyoRegulator device, based on PathMaker’s DoubleStim technology, is designed to provide simultaneous, non-invasive stimulation at spinal and peripheral locations, the Boston and Paris-based company said.

The money comes as part of a four-year grant awarded through the CREATE Devices program which also provides a partnership with the NIH’s National Institute of Neurological Disorders and Stroke, PathMaker said.

“We are truly honored and delighted to receive this support from NINDS to advance our breakthrough non-invasive neuromodulation technology that can benefit many patients in desperate need of treatment options. This collaborative partnership and funding will support product engineering, multi-center U.S. pivotal trials and regulatory submission for MyoRegulator,” prez & CEO Dr. Nader Yaghoubi said in a press release.

“The CREATE Devices program encourages the pursuit of translational and clinical studies for innovative therapeutic devices to treat neurological disorders,” NINDS program director Nick Langhals said in a prepared statement.

Last February, PathMaker Neurosystems said that it won a grant from BpiFrance to support its MyoRegulator neurostim device.

Filed Under: Business/Financial News, Neuromodulation/Neurostimulation Tagged With: PathMaker Neurosystems Inc.

In case you missed it

  • Neuromod dev ENeura raises $17m in Series D
  • Masimo wins CE Mark for Eve newborn CCHD screening app
  • India’s medical device industry protests NPPA stent price caps
  • Zenflow raises $31m in Series A
  • Impel NeuroPharma touts proof-of-concept trial for intranasal migraine drug
  • NIH inks $5m partnership with PathMaker Neurosystems for MyoRegulator spasticity device
  • How the Apple Watch & other wearables could help highlight early signs of diabetes
  • Appeals court upholds $19m Boston Scientific loss in pelvic mesh case
  • Abbott’s FreeStyle Libre glucose monitoring app launches in Europe
  • FDA dings Zimmer Biomet over issues at Indiana plant
  • Sales for Sanofi’s U.S. diabetes biz fall -30% in Q4
  • Teva inks deal to test drugs with ProBioGen’s artificial lymph node tech
  • Titan Medical pushes FDA submission back to 2019, looks to US stock market cross listing
  • Allurion launches pivotal US Elipse gastric balloon trial
  • Empatica wins FDA nod for Embrace seizure-tracking wristband
  • Study: Long-term use of inhaled corticosteroids may heighten risk of bone fractures in COPD patients
  • Haemonetics shares rise on Q3 beat

RSS From Medical Design & Outsourcing

  • Steve Maxson joins Fermatex as VP of marketing and sales
    Fermatex Vascular Technologies (formerly Gore-Jersey Shore and Adam Spence Corporation) recently announced that Steve Maxson has joined the company as VP of marketing and sales. “I’m very pleased to have Steve join the Fermatex team at this exciting time of transition and growth. His technical experience and commitment to responsive service will ensure that we remain […]
  • Nearly 90% of clinicians will use bedside mobile tech by 2022
    A new study from Zebra Technologies reports that 9 out of 10 clinicians will use mobile technology at the bedside for acute care within the next four years. The company received feedback from 1,500 nursing managers, IT decision-makers and patients to determine how patient care will transform by 2022. The ability to use mobile devices […]
  • TRUMPF touts newest laser technology at Photonics West
    TRUMPF is touting its TruMicro 5370 and TruMicro 7380, Dira 200-5 and a TruLaser Station 5005 with a TruMicro 2030 laser system Photonics West in San Francisco, Calif. at booth #817. The company’s short and ultra-short pulsed TruMicro 5370 and 7380 lasers are designed for micro-processing. They are used in standard processing methods like cutting, drilling, […]
  • Dow touts versatility in latest LSR grades for overmolding
    Dow Medical Solutions, a business unit of the DowDuPont Specialty Products Division has introduced two new liquid silicone rubber (LSR) technologies to support a broader range of rigid plastic substrates for overmolding applications. These new elastomeric products give designers and manufacturers greater options for creating differentiated devices with improved safety and durability. The two grades include […]
  • Spectralytics launches DFM product development facility for laser services
    In the new medtech manufacturing environment, design engineers need parts faster, with fewer iterations and quicker turnaround. Spectralytics aims to meet those needs with its revamped development center in Maple Plain, Minn. The laser cutting and processing contract manufacturer has a newly expanded facility dedicated to design and prototyping. The 15,000 sq. ft. facility is located […]
  • Mack Molding systematizes ISO 9001 and 13485 revisions
    Mack Molding recently announced that is has started the process of systematizing ISO 9001:2015 and ISO 13485:2016 fifth and third revisions for medical devices. The company plans to train internal auditors to help assure that Mack Molding is ready to be certified after audits that are scheduled for July. “When we first implemented ISO 9001 […]
  • GW Plastics expands in-house tooling capabilities
    GW Plastics (Royalton, Vt.) recently announced that it has expanded and upgraded its tooling facility, adding additive manufacturing technology. The company has invested in medical 3D printing technology to help with conformal cooling and improve cycle times up to 30%. “This additive manufacturing technology streamlines tool design, reducing the components needed to build a mold […]
  • Raumedic investing in modernizing headquarters
    Raumedic (Helmbrechts, Germany) is investing 1 million Euros in expanding and modernizing its German headquarters. The company will add a state-of-the-art customer center while improving working conditions for employees. The company is adding a new foyer with additional meeting areas. The older buildings at the Helmbrechts-based headquarters will be the main areas undergoing modernization, which […]
  • Software is a top cause of medical device recalls: Here’s what you can do
    Stericycle Expert Solutions recently conducted a five-year assessment of recall trends, based on its quarterly Recall Index studies. The results show surprising missteps from medical device companies, especially where software is concerned. We asked Chris Harvey, director of recall solutions at Stericycle to answer some questions about the recall trends and offer some advice on […]
  • Report: Medical device recalls down in Q4 of 2017
    The medical device industry saw a 9% decline in recalls in the last quarter of 2017, the lowest quarter since the fourth quarter of 2011. Stericycle Expert Solutions reports in its annual Recall Index that one of the major causes of medical device recalls over the past five years is technological advances. Chris Harvey, director […]
  • Webinar: How a 3D printer’s versatility enables medical innovation
    Wednesday, Feb. 21, 2018 11:30am Eastern time / 8:30am Pacific time     View this webinar to learn how 3D printing’s versatility has paved the way for medical advancements by Cardiovascuar Systems. To help fight the battle against CAD and PAD, CSI works continuously to advance their devices and develop new innovations – work that […]

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Privacy
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Connect with us on Google PlusGoogle+

Copyright © 2018 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy